DE FERRA, LORENZO,JAEGER, RALF,PURPURA, MARTIN,HEUER, MARVIN,HAGERMAN, SCOTT
申请号：
CA2873840
公开号：
CA2873840A1
申请日:
2013.05.20
申请国别(地区):
CA
年份:
2013
代理人:
摘要：
Phosphatidic acid, lyso-phosphatidic acid, glycerol-3-phosphate and/or phospholipase D can be administered to exercising mammals to increase muscle mass and strength. These actives can be administered orally to aging, bedridden or cachectic patients to improve nitrogen balance. A highly suitable form of phosphatidic acid for administration is phosphatidic acid-enriched lecithin. Creatine can be co-administered orally to increase muscle-building and strength-enhancing effects. Other additives can include nutritional and herbal supplements, micronutrients and hormones.
